Literature DB >> 28296286

Nanomedicine approaches to improve cancer immunotherapy.

Hui Qiu1,2, Yuanzeng Min1, Zach Rodgers1, Longzhen Zhang2,3, Andrew Z Wang1,2.   

Abstract

Significant advances have been made in the field of cancer immunotherapy by orchestrating the body's immune system to eradicate cancer cells. However, safety and efficacy concerns stemming from the systemic delivery of immunomodulatory compounds limits cancer immunotherapies expansion and application. In this context, nanotechnology presents a number of advantages, such as targeted delivery to immune cells, enhanced clinical outcomes, and reduced adverse events, which may aid in the delivery of cancer vaccines and immunomodulatory agents. With this in mind, a diverse range of nanomaterials with different physicochemical characteristics have been developed to stimulate the immune system and battle cancer. In this review, we will focus on some recent developments and the potential advantages of utilizing nanotechnology within the field of cancer immunotherapy. WIREs Nanomed Nanobiotechnol 2017, 9:e1456. doi: 10.1002/wnan.1456 For further resources related to this article, please visit the WIREs website.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh：

Year:  2017        PMID： 28296286      PMCID： PMC5561449          DOI： 10.1002/wnan.1456

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN： 1939-0041


  81 in total

1.  The use of calcium phosphate nanoparticles encapsulating Toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation.

Authors:  Viktoriya Sokolova; Torben Knuschke; Anna Kovtun; Jan Buer; Matthias Epple; Astrid Maria Westendorf
Journal:  Biomaterials       Date:  2010-04-24       Impact factor: 12.479

2.  Intracellular Delivery of Charge-Converted Monoclonal Antibodies by Combinatorial Design of Block/Homo Polyion Complex Micelles.

Authors:  Ahram Kim; Yutaka Miura; Takehiko Ishii; Omer F Mutaf; Nobuhiro Nishiyama; Horacio Cabral; Kazunori Kataoka
Journal:  Biomacromolecules       Date:  2016-01-04       Impact factor: 6.988

3.  Efficient nontoxic delivery of PD-L1 and PD-L2 siRNA into dendritic cell vaccines using the cationic lipid SAINT-18.

Authors:  Mieke W H Roeven; Willemijn Hobo; Robbert van der Voort; Hanny Fredrix; Wieger J Norde; Kasper Teijgeler; Marcel H J Ruiters; Nicolaas Schaap; Harry Dolstra
Journal:  J Immunother       Date:  2015-05       Impact factor: 4.456

4.  Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.

Authors:  Amanda L Gavin; Kasper Hoebe; Bao Duong; Takayuki Ota; Christopher Martin; Bruce Beutler; David Nemazee
Journal:  Science       Date:  2006-12-22       Impact factor: 47.728

5.  Intranasal administration of CpG DNA lipoplex prevents pulmonary metastasis in mice.

Authors:  Shuwen Zhou; Shigeru Kawakami; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Cancer Lett       Date:  2009-08-05       Impact factor: 8.679

6.  Programmed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cells.

Authors:  Min Beom Heo; Yong Taik Lim
Journal:  Biomaterials       Date:  2013-10-11       Impact factor: 12.479

7.  Enhanced immunotherapy of SM5-1 in hepatocellular carcinoma by conjugating with gold nanoparticles and its in vivo bioluminescence tomographic evaluation.

Authors:  Xibo Ma; Hui Hui; Yushen Jin; Di Dong; Xiaolong Liang; Xin Yang; Ke Tan; Zhifei Dai; Zhen Cheng; Jie Tian
Journal:  Biomaterials       Date:  2016-02-08       Impact factor: 12.479

8.  Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles.

Authors:  Saijie Zhu; Mengmeng Niu; Hannah O'Mary; Zhengrong Cui
Journal:  Mol Pharm       Date:  2013-08-06       Impact factor: 4.939

9.  Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity.

Authors:  Samar Hamdy; Ommoleila Molavi; Zengshuan Ma; Azita Haddadi; Aws Alshamsan; Zahra Gobti; Sara Elhasi; John Samuel; Afsaneh Lavasanifar
Journal:  Vaccine       Date:  2008-08-03       Impact factor: 3.641

10.  Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.

Authors:  Jinming Li; Yanli Sun; Tingting Jia; Rui Zhang; Kuo Zhang; Lunan Wang
Journal:  Int J Cancer       Date:  2013-10-08       Impact factor: 7.396
View more
  9 in total

Review 1.  Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine.

Authors:  Francis Man; Peter J Gawne; Rafael T M de Rosales
Journal:  Adv Drug Deliv Rev       Date:  2019-06-03       Impact factor: 15.470

2.  Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor-An Opportunity for Cancer Treatment.

Authors:  Mohammad A I Al-Hatamleh; Engku Nur Syafirah E A R; Jennifer C Boer; Khalid Ferji; Jean-Luc Six; Xin Chen; Eyad Elkord; Magdalena Plebanski; Rohimah Mohamud
Journal:  Cells       Date:  2019-12-20       Impact factor: 6.600

Review 3.  Targeting the "Sweet Side" of Tumor with Glycan-Binding Molecules Conjugated-Nanoparticles: Implications in Cancer Therapy and Diagnosis.

Authors:  Nora Bloise; Mohammad Okkeh; Elisa Restivo; Cristina Della Pina; Livia Visai
Journal:  Nanomaterials (Basel)       Date:  2021-01-22       Impact factor: 5.076

Review 4.  Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine.

Authors:  C Tilden Hagan; Yu Mi; Nicole M Knape; Andrew Z Wang
Journal:  Bioconjug Chem       Date:  2020-11-30       Impact factor: 4.774

Review 5.  Polymeric Micelles in Cancer Immunotherapy.

Authors:  Zhuoya Wan; Ruohui Zheng; Pearl Moharil; Yuzhe Liu; Jing Chen; Runzi Sun; Xu Song; Qiang Ao
Journal:  Molecules       Date:  2021-02-25       Impact factor: 4.411

Review 6.  Toxicity of gold nanoparticles (AuNPs): A review.

Authors:  A Sani; C Cao; D Cui
Journal:  Biochem Biophys Rep       Date:  2021-04-10

Review 7.  Harnessing the Immunogenic Potential of Gold Nanoparticle-Based Platforms as a Therapeutic Strategy in Breast Cancer Immunotherapy: A Mini Review.

Authors:  Xiao-Yang Chen; Lin-Yue Lanry Yung; Puay Hoon Tan; Boon Huat Bay
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

8.  Nanoparticles for "two color" 19F magnetic resonance imaging: Towards combined imaging of biodistribution and degradation.

Authors:  Olga Koshkina; Paul B White; Alexander H J Staal; Ralf Schweins; Edyta Swider; Ilaria Tirotta; Paul Tinnemans; Remco Fokkink; Andor Veltien; N Koen van Riessen; Ernst R H van Eck; Arend Heerschap; Pierangelo Metrangolo; Francesca Baldelli Bombelli; Mangala Srinivas
Journal:  J Colloid Interface Sci       Date:  2019-12-18       Impact factor: 8.128

Review 9.  Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer.

Authors:  Alba Navarro-Ocón; Jose L Blaya-Cánovas; Araceli López-Tejada; Isabel Blancas; Rosario M Sánchez-Martín; María J Garrido; Carmen Griñán-Lisón; Jesús Calahorra; Francisca E Cara; Francisco Ruiz-Cabello; Juan A Marchal; Natalia Aptsiauri; Sergio Granados-Principal
Journal:  Pharmaceutics       Date:  2022-02-25       Impact factor: 6.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.